3 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 1 | 2 | Unknown 2 |
Follow Interleukin-7: new trials by email Literature Review of Interleukin-7 trials Research Report on Interleukin-7
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma. Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells - B Cell Lymphoma | Phase 2 | Unknown | Wenbin Qian | 80 | 2019-03-28 | 2019-04-26 |
| Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy Interleukin-7 - Hepatitis C | Phase 1 / Phase 2 | Unknown | Cytheris SA | 15 | 2009-01-01 | 2012-10-18 |
| Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone Interleukin-7 - Hepatitis C | Phase 1 / Phase 2 | Unknown | Cytheris SA | 18 | 2008-07-01 | 2012-10-18 |
Hepatitis C (2) · Hepatitis, Chronic (2) · Liver Diseases (2) · Virus Diseases (2) · Lymphoma, B-Cell (1)
Cytheris SA (2) · Wenbin Qian (1)
China (1) · France (1) · Italy (1) · Switzerland (1) · Taiwan (1)
Tilman Gerlach (1) · Wang-Long Chuang, MD (1) · Wenbin Qian, MD，PhD (1)